NCT03755804: Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17 |
|
|
| Recruiting | 2 | 250 | US | bendamustine, TREANDA (R), Etoposide, VP-16, Vepeside, Doxorubicin, Adriamycin (R), Bleomycin, Blenoxane (R), Vincristine, Oncovin (R), Vinblastine, Velban (R), Prednisone, Prednisolone, Filgrastim, Neupogen (R), Brentuximab Vedotin, Adcetris, Cyclophosphamide, Cytoxan (R), DTIC, DACARBAZINE (R), Dimethyl Triazeno Imidazole Carboximide, Quality of Life Measurements, Quality of Life Measurements (QOL), Radiotherapy, radiation therapy, irradiation | St. Jude Children's Research Hospital, Teva Pharmaceuticals USA, Seagen Inc. | Hodgkin Lymphoma | 01/27 | 07/28 | | |
| Recruiting | N/A | 1247 | Europe, Canada, US | Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System | Edwards Lifesciences | Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation | 01/25 | 04/30 | | |
NCT02322840: Transcatheter Mitral Valve Replacement System (TMVR) Pilot Study and The Early Feasibility Study of the TMVR Transseptal System |
|
|
| Active, not recruiting | N/A | 33 | Europe, US, RoW | Twelve TMVR Implant, Medtronic Intrepid™ Transcatheter Mitral Valve Replacement System, Medtronic Intrepid™ Transcatheter Transfemoral Mitral Valve Replacement System | Medtronic Cardiovascular, Medtronic | Mitral Valve Insufficiency | 09/22 | 12/28 | | |
